About Amunix
amunix is an immuno-oncology company leveraging our proprietary, clinically validated pro-xten technology platform to discover and develop transformative t cell engagers (tces) and c... Read more
amunix is an immuno-oncology company leveraging our proprietary, clinically validated pro-xten technology platform to discover and develop transformative t cell engagers (tces) and c... Read more